Replies to post #12249 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Should be abit over 12M now...with latest [fibrinogen] deal.<

$11.7M of “existing” cash means existing as of the latest quarterly report, i.e. 1Q08.

I preume that GTC’s assertion of cash neutrality in 2Q08 takes into acount the $550K received for the fibrinogen deal, so we need not make any adjustment to the guidance in #msg-30250952.